Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access ...

GE HealthCare beats Q1 estimates and sees strong order growth, but tariff concerns prompt analysts to cut price targets ...

Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning ...

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday. Shares of CVS Health Corporation CVS ...

US manufacturing sector continues to shrink in April amid weakening demand and rising price pressures from tariffs, ISM data ...

Qualcomm is guiding for third-quarter revenue to come in a range of $9.9 billion to $10.7 billion. Analysts expect $10.35 ...

However, the increasing costs as well as the delays in development forced the Detroit-based automaker to abandon the project, ...

Adial secures USPTO patent for AD04, expanding coverage to treat alcohol and opioid-related disorders in patients with ...

Analysts have set 12-month price targets for Wolverine World Wide, revealing an average target of $19.4, a high estimate of ...

Global health experts warn that US retreat from TB prevention programs could lead to a resurgence of the deadliest infectious ...

Tesla's board reportedly began searching for a successor to Elon Musk last month due to financial setbacks, with Musk ...

U.S. stock futures rose early Thursday morning, following the robust earnings of two "Mag 7" companies after markets closed ...